Synova Partners’ cover photo
Synova Partners

Synova Partners

Staffing and Recruiting

Shaping the future of MedTech, one hire at a time.

See jobs Follow

About us

At Synova our mission is simple; to build high-performing teams for early-stage MedTech companies, empowering them to fulfil their goal of bringing life-saving innovation to the market. What sets us apart is our deep industry expertise and global reach. We’ve worked alongside some of the most disruptive MedTech start-ups and leading VC firms, delivering strategic talent solutions that drive growth and innovation. Whether it’s building executive leadership teams or placing top-tier individual contributors, we are committed to being the go-to search partner that helps MedTech companies scale, succeed, and transform patient care worldwide.

Website
https://synova-partners.com/
Industry
Staffing and Recruiting
Company size
2-10 employees
Headquarters
Leeds
Type
Privately Held
Founded
2025

Locations

Employees at Synova Partners

See all employees

Updates

  • Synova Partners reposted this

    View profile for Myles Clegg
    Myles Clegg

    Next week, Synova Partners will attend PCR London Valves, one of the key events on the structural heart calendar. It’s always a highlight of the year to connect with innovators and founders who are pushing the boundaries of what’s possible in #TAVR, #TMVR, #tricuspid, and other #structuralheart interventions. At Synova Partners, we’re proud to work closely with the companies driving these advances, from early-stage start-ups bringing first-in-human data to the table to commercial-stage companies expanding globally. If you’re attending and would like to connect, whether to discuss your company’s growth plans, share ideas from the conference, or just grab a coffee, feel free to reach out. #MedTech #StructuralHeart #Cardiovascular #TAVR #TMVR #Tricuspid #SynovaPartners #PCRLondonValves #medicaldevices #medtech #pcrlv

    • No alternative text description for this image
  • View organization page for Synova Partners
    Synova Partners

    800 followers

    🚀 𝐌𝐞𝐝𝐓𝐞𝐜𝐡 𝐅𝐮𝐧𝐝𝐢𝐧𝐠 𝐑𝐨𝐮𝐧𝐝𝐮𝐩 - 𝐒𝐞𝐩𝐭𝐞𝐦𝐛𝐞𝐫 💰 Over $400M was poured into #medtech in September, with #diabetes, #neuromodulation, #surgicalrobotics, and #ablation technologies taking centre stage. 🔎 𝐓𝐨𝐩 𝐃𝐞𝐚𝐥𝐬 ⛽ Kaleido brings in $85M Series D round to support next-gen automated insulin patch pump. Thomas Arnold ⚡ Galvanize secures an oversubscribed $100 million Series C round to advance its Aliya pulsed electric field (PEF) technology for solid tumours and chronic bronchitis. Doug Godshall, Jonathan Waldstreicher, MD 🪃 Boomerang Medical closes $20M for its sacral neuromod tech for inflammatory bowel disease. Heather Simonsen 🤖 Microbot Medical to generate $92M from stock sale. Harel Gadot ⚡ Nalu Medical, Inc. picks up $50M in growth funding for its spinal cord stimulation and peripheral nerve stimulation (PNS) technology. Thomas A. West 🤖 AiM Medical Robotics closes $8.1M Series A round. Gregory Fischer 🫀 Axon Therapies Inc. raises $32M in an oversubscribed Series A round in its bid to transform heart failure treatment. Zoar Engelman 🦴 Spineart announces CHF 25M capital raise from longstanding investors. Jerome Trividic 🤖 Ronovo Surgical secures sizeable Series D round, totalling over $100M in funding raised this year alone. John Ma, Ph.D. 📌 Stay tuned next month for October's roundup! #medtech #funding #heartfailure #cardiology #insulin #startups #medicaldevices

  • Synova Partners reposted this

    View profile for James Gillman
    James Gillman

    Thank you, LSI Europe for another fantastic week of insightful discussions with #Investors, #Strategics and #Innovators. Events like this, where innovators come together to share how their technologies can improve the lives of patients around the world, are a powerful reminder of why I’m proud to be part of such a meaningful and inspiring industry. Synova Partners launched only 8 weeks ago, and while we’re a new firm, we bring over 20 years of experience in this space. This was our first event as a newly formed search firm dedicated to partnering with early stage start-ups to help them scale globally when the time comes. A big thank you to everyone we met, it was a pleasure, and we look forward to seeing you again soon! #LSIeurope #medtech #innovation #globalsearch #startups #raisingcapital #synovapartners 🚀 🚀 🚀

    • No alternative text description for this image
    • No alternative text description for this image
  • View organization page for Synova Partners
    Synova Partners

    800 followers

    Over the years, James Gillman and Myles Clegg at Synova Partners have had the fortune of being trusted by some of the most innovative and disruptive start-ups in #MedTech to help build their executive leadership teams. With close to 30 years of combined experience, we understand the critical importance of appointing the right leaders to guide a company through pivotal growth stages. 👇 Take a look at some of our executive search work below, and if you’re a MedTech founder or investor looking for exceptional leadership, or an executive exploring your next opportunity, we’d love to talk.

    • No alternative text description for this image

  • Synova Partners reposted this

    View profile for Myles Clegg
    Myles Clegg

    𝗪𝗲𝗲𝗸𝗹𝘆 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝗥𝗼𝘂𝗻𝗱-𝗨𝗽! 💰 Funding news 💰 Apreo Health announced that it closed an oversubscribed $130 million Series B financing round to support its Breathe airway scaffold. The company also plans to use funds to support regulatory activities related to the trial and early commercialisation efforts for Breathe. Karun Naga CardiacBooster secures $10.8M for ventricular assist device. The funding, from Ireland’s Disruptive Technologies Innovation Fund (DTIF), supports the development of CardiacBooster’s unique mechanical cardiac support technology into a comprehensive medical device platform for treating cardiogenic shock. Florian Ludwig Orchestra BioMed announced that it completed strategic transactions and equity offerings worth an expected $111.2 million. Proceeds support the continued advancement of its late-stage atrioventricular interval modulation (AVIM) therapy and Virtue sirolimus angioinfusion balloon (SAB) clinical programs. David Hochman 🚀 Regulatory Approvals & Product Launches 🚀 Instylla announced that it received #FDA premarket approval (PMA) for its Embrace hydrogel embolic system for the embolisation of hypervascular tumours (HVTs) in peripheral arteries ≤ 5 mm. Sean Boyle Abbott launches its latest-generation MitraClip and TriClip G5 systems. Respiree announced that it received a second FDA 510(k) clearance for its RS001 cardio-respiratory wearable device. The expanded FDA clearance covers the use of the wearable in home environments. Gurpreet Singh Getinge announced that the European regulatory authorities reinstated the CE mark for its Cardiosave intra-aortic balloon pump. The Swedish medtech company faced a temporary suspension of the technology in March 2024. 🔬 Clinical Updates 🔬 Distalmotion announced new milestones as it continues clinical trial plans to support indication expansions for its Dexter surgical robot. The company continues to take the steps toward bringing the robot to ventral hernia repair, sacrocolpopexy, and myomectomy trials. Greg Roche TransMedics, Inc. gets FDA green light to begin next-gen heart perfusion trial. Waleed Hassanein, MD Synchron today presented the first-ever public demonstration of an individual using an Apple iPad controlled entirely by thought. Thomas Oxley 🔎 Mergers, Acquisitions & IPO's 🔍 Heartflow sets IPO price at up to $300M. With the IPO, the company expects to use proceeds to fund sales and marketing, fund R&D and for other general corporate purposes. John Farquhar HistoSonics, Inc. announced a management-led majority stake acquisition by a syndicate of private and public investors. The deal for the histotripsy therapy platform developer is valued at approximately $2.25 billion. Edwards Lifesciences announced that the U.S. Federal Trade Commission (FTC) seeks to block its planned $1.2 billion acquisition of JenaValve Technology, Inc.. Alcon to acquire STAAR Surgical in $1.5B deal. Synova Partners #medtech

  • Synova Partners reposted this

    View profile for Myles Clegg
    Myles Clegg

    𝗪𝗲𝗲𝗸𝗹𝘆 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝗥𝗼𝘂𝗻𝗱-𝗨𝗽! 💰 Funding news 💰 Apreo Health announced that it closed an oversubscribed $130 million Series B financing round to support its Breathe airway scaffold. The company also plans to use funds to support regulatory activities related to the trial and early commercialisation efforts for Breathe. Karun Naga CardiacBooster secures $10.8M for ventricular assist device. The funding, from Ireland’s Disruptive Technologies Innovation Fund (DTIF), supports the development of CardiacBooster’s unique mechanical cardiac support technology into a comprehensive medical device platform for treating cardiogenic shock. Florian Ludwig Orchestra BioMed announced that it completed strategic transactions and equity offerings worth an expected $111.2 million. Proceeds support the continued advancement of its late-stage atrioventricular interval modulation (AVIM) therapy and Virtue sirolimus angioinfusion balloon (SAB) clinical programs. David Hochman 🚀 Regulatory Approvals & Product Launches 🚀 Instylla announced that it received #FDA premarket approval (PMA) for its Embrace hydrogel embolic system for the embolisation of hypervascular tumours (HVTs) in peripheral arteries ≤ 5 mm. Sean Boyle Abbott launches its latest-generation MitraClip and TriClip G5 systems. Respiree announced that it received a second FDA 510(k) clearance for its RS001 cardio-respiratory wearable device. The expanded FDA clearance covers the use of the wearable in home environments. Gurpreet Singh Getinge announced that the European regulatory authorities reinstated the CE mark for its Cardiosave intra-aortic balloon pump. The Swedish medtech company faced a temporary suspension of the technology in March 2024. 🔬 Clinical Updates 🔬 Distalmotion announced new milestones as it continues clinical trial plans to support indication expansions for its Dexter surgical robot. The company continues to take the steps toward bringing the robot to ventral hernia repair, sacrocolpopexy, and myomectomy trials. Greg Roche TransMedics, Inc. gets FDA green light to begin next-gen heart perfusion trial. Waleed Hassanein, MD Synchron today presented the first-ever public demonstration of an individual using an Apple iPad controlled entirely by thought. Thomas Oxley 🔎 Mergers, Acquisitions & IPO's 🔍 Heartflow sets IPO price at up to $300M. With the IPO, the company expects to use proceeds to fund sales and marketing, fund R&D and for other general corporate purposes. John Farquhar HistoSonics, Inc. announced a management-led majority stake acquisition by a syndicate of private and public investors. The deal for the histotripsy therapy platform developer is valued at approximately $2.25 billion. Edwards Lifesciences announced that the U.S. Federal Trade Commission (FTC) seeks to block its planned $1.2 billion acquisition of JenaValve Technology, Inc.. Alcon to acquire STAAR Surgical in $1.5B deal. Synova Partners #medtech

  • View organization page for Synova Partners
    Synova Partners

    800 followers

    Weekly #MedTech Round-up... 💰 Funding news 💰 London-based company Sava raised $19 million in a Series A financing round to support its wearable biosensor technology. Renato Circi Rafaël Michali InspireMD raises $58M to fund the launch of CGuard Prime in the U.S. market. Marvin Slosman MAUI Imaging announced that it raised $14 million in a Series D financing round to support its echo tomography-based imaging technology. David Specht #Tricuspid repair startup Versa Vascular raises $27.3M and emerges from stealth mode. Maggie Nixon 🚀 Regulatory approvals & Product launches 🚀 EvoEndo announced that it received expanded #FDA clearance for its Model LE gastroscope, covering patients of all ages. Jonathan Hartmann SetPoint Medical announced that the FDA has approved its SetPoint neuroimmune modulation system for the treatment of rheumatoid arthritis (RA). Murthy Simhambhatla Cardiosense announced today that it received FDA 510(k) clearance for its CardioTag wearable sensor device. Amit Gupta Bioventus wins FDA nod for duo of next-generation peripheral nerve stimulation products. Anthony Doyle Inari Medical, now part of Stryker, announced the launch of its next-generation InThrill #thrombectomy system. Stereotaxis gets FDA green light for robotic #electrophysiology mapping catheter. David Leo Fischel 🔬 Clinical updates 🔬 Vexev completes enrollment in study of robotic ultrasound for AV fistula mapping. Eamonn Colley CorTec announced the first human implantation of its proprietary brain-computer interface (BCI) system, Brain Interchange. Frank Desiere - PhD MBA Monogram Technologies announces first autonomous saw-based robotic knee replacement procedure. Benjamin Sexson, CFA INBRAIN Neuroelectronics reports positive interim results for #BCI tech. Carolina Aguilar AngioDynamics announced that it enrolled its first patient in a randomised study of its Auryon atherectomy system. Laura Piccinini Cognito Therapeutics, Inc. announced the presentation of new findings from a study of its non-invasive Spectris #neuromodulation system. Supporting the clinical efficacy and neuroprotective mechanism of Spectris in patients with #Alzheimer’s disease. Christian Howell 🔎 Key leadership appointments 🔍 Vicarious Surgical Inc. announced the appointment of Stephen From as CEO, effective Aug. 7, 2025. InspireMD announced the appointment of Raymond W. Cohen to its board of directors. Cohen brings more than 40 years of leadership experience to the InspireMD board. Dexcom to promote COO Jake Leach to CEO, succeeding Kevin Sayer.

  • View organization page for Synova Partners
    Synova Partners

    800 followers

    At Synova Partners, James Gillman and Myles Clegg have had the privilege of supporting some of the most disruptive start-ups in #MedTech, helping them build out high-performing commercial teams across the US and Europe. From #heartfailure to #neurovascular, #neuromodulation to #interventionalcardiology, we understand the importance of hiring A-grade talent at the first time of asking. With nearly three decades of combined experience and a deep, global network of field sales, marketing, and commercial leadership talent, we’re here to help you build teams that will help achieve your goals. 👉 Take a look at some of the work we have done below, and if you’re a commercial leader looking to hire or a MedTech professional exploring your next move, please get in touch!

Similar pages